Cantuzumab mertansine
Product Specifications
CAS Number
400010-39-1
Target
Antibody-Drug Conjugates (ADCs) |||Microtubule Associated
Related Pathways
Antibody-drug Conjugate/ADC Related|||Cytoskeletal Signaling
Bioactivity
Cantuzumab mertansine (SB-408075; huC242-DM1), an antibody-drug conjugate (ADC), comprises the potent maytansine derivative (DM1) linked to the humanized monoclonal antibody (huC242) targeting CanAg. Demonstrating cytotoxicity against colon cancer cells, this compound shows extensive antitumor effectiveness across various CanAg-positive human tumor xenografts [1] [2].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7041237-01 0.02 mg
Recombinant Vaccinia virus Late protein H7 (MVA097R, ACAM3000_MVA_097)
Ask
View Details MBS7041237-02 0.1 mg
Recombinant Vaccinia virus Late protein H7 (MVA097R, ACAM3000_MVA_097)
Ask
View Details MBS7041237-03 5x 0.1 mg
Recombinant Vaccinia virus Late protein H7 (MVA097R, ACAM3000_MVA_097)
Ask
View Details 